• Journal of Internet of Things and Convergence
• /
• v.6 no.1
• /
• pp.23-30
• /
• 2020

This paper proposes energy management directions to discover the factors of energy loss in homes and buildings and to find ways to improve them. We designed a diagnostic content app for everyday life so that not only housing experts but also the general public can use the detachable thermal imaging camera, which is a strong point of popularity and convenience. The diagnostic results using the app were analyzed using Energy Finder, an energy efficiency diagnostic solution. The survey was conducted on the senior center which is in the blind spots and facilities of the energy welfare area. The target of diagnosis was energy efficiency diagnosis by selecting 30 senior centers for over 15 years from 600 locations located in Naju City, Jeollanam-do. The overall diagnosis was good, but it is considered that the place classified as 7th grade needs to be supplemented to improve energy efficiency.

• The Korean Journal of Nuclear Medicine
• /
• v.31 no.4
• /
• pp.427-432
• /
• 1997

Re-188 is useful candidate for therapeutic radionuclide because it has a physical half life of 17 hours, contains beta emissions suitable for therapy(maximum energy 2.12MeV) and emits a gamma ray that is suitable for quantitative diagnostic scanning(155keV). To use Re-188 as a radionuclide compound of angioplasty balloon radiotherapy, we investigated the labelling method and biodistribution of Re-188-DTPA We postulated that labeled Re-188-DTPA is preferable because it would be excreted via urinary system more easily than other compounds. To label Re-188 with DTPA, 1ml of 222MBq(6mCi) of Re-188 was added to DTPA solution(DTPA 20mg, $SnCl_2{\cdot}2H_2O$ 10mg, pH 3.5) and boiled at $100^{\circ}C$ for 120min in water bath. pH was adjusted to 5 with 2.3% sodium acetate. Labeling efficiency was measured using TLC-SG(acetone, saline). We evaluated biodistribution of Re-188-DTPA in sacrificed mice at 10 and 60 minutes after injection. We acquired images of kidneys, and drew time-activity curves in normal dogs and rats and calculated Tmax and Tl/2 in rats. The labelling efficiency was 95.7% on average. Labelling of Re-188-DTPA was.stable(90% after 5hours) in vitro at room temperature. According to time-activity curves of dogs and rats, it took 15 to 20 minutes after injection for Re-188-DTPA to be washed out through kidneys. In conclusion, Re-188-DTPA was successfully labeled, Re-188-DTPA was stable in vitro and was excreted early via kidneys in animals. We could recommend Re-188-DTPA as radionuclide of potential use in angioplasty balloon radiotherapy.